4
Changes in Ownership
Beam Therapeutics Inc. Filed Acc 0000950170-24-010477
CEO sold 60,000 shares at $25.33 ($1,519,800)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Evans John M. CEO | 2024-01-31 | Sale 10b5-1 | −60,000 | $25.33 | $1,519,800 | 1,058,262 | D |
| Derivatives | |||||||
| Evans John M. CEO | 2024-01-31 | Grant or award · Stock Option (Right to Buy) 10b5-1 | +155,000 | $24.40 | $3,782,000 | 155,000 | D |
| Open-market sales · 60,000 sh · avg $25.33 · $1,519,800 | |||||||
Loading xslF345X05/ownership.xml…